Intra Cellular Therapies | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Cytokinetics USD -386323000 52.48M 2023-12
Gilead Sciences USD 22.75B 435M 2023-12
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
RedHill Biopharma USD 3.47M 1.47M 2023-06
Supernus Pharmaceuticals USD 921.52M 9.32M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12



Intra Cellular Therapies Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.